![]() |
市場調查報告書
商品編碼
1519525
2024-2032 年按產品、適應症、配銷通路和地區分類的馬保健市場Equine Healthcare Market by Product, Indication, Distribution Channel, and Region 2024-2032 |
IMARC Group年,全球馬保健市場規模達15億美元。馬匹數量的快速增加、馬主對馬匹健康和適當營養的認知不斷提高以及先進成像技術的利用是推動市場發展的一些關鍵因素。
馬醫療保健是獸醫學的一個分支,專注於馬疾病的診斷、治療和預防。它涉及各種產品的利用,如疫苗、驅蟲劑、局部治療、關節補充劑、益生元、滅蠅噴霧劑、蹄部調理劑、防腐劑和功能添加劑。馬醫療保健包括預防護理、疾病管理、跛行治療、生殖護理、口腔衛生、復健和解決行為問題。它有助於改善整體健康,預防未來的併發症,允許早期疾病檢測,促進成功繁殖,促進更長的壽命,並降低嚴重疾病的風險,如跛行、牙齒問題、感染、肥胖、皰疹和狂犬病。
由於馬匹廣泛用於賽馬、農耕和作為伴侶,馬匹數量迅速增加,這是推動市場成長的主要因素之一。馬保健服務和產品,如預防保健、生殖服務、復健中心、疫苗和保健品,被廣泛使用,以確保最佳性能、預防併發症、防止受傷並降低疾病風險。除此之外,馬主對馬健康和適當營養重要性的認知不斷提高,也是另一個促進生長的因素。此外,政府實施的各種支持動物福利、促進負責任的所有權和提供高品質醫療設施的措施正在對市場成長產生積極影響。此外,利用先進的成像技術,如數位射線照相、超音波和內視鏡檢查,提供馬身體的詳細橫斷面影像,從而可以診斷肌肉骨骼損傷、跛行和內科疾病,正在為市場做出貢獻。除此之外,最近開發的馬匹穿戴式健康監測設備可以持續監測生命徵象、活動量和行為,以便及早發現任何健康問題,這為市場成長提供了動力。此外,賽馬、障礙賽、盛裝舞步和耐力賽等馬術運動的不斷增加正在推動市場的成長。其他因素,包括消費者支出能力的提高、寵物人性化的新興趨勢、廣泛的研發(R&D)活動以及電子商務行業的快速擴張,預計將推動市場成長。
The global equine healthcare market size reached US$ 1.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2032, exhibiting a growth rate (CAGR) of 5.6% during 2024-2032. The rapid increase in the equine population, rising awareness among owners regarding equine health and proper nutrition, and the utilization of advanced imaging techniques represent some of the key factors driving the market.
Equine healthcare is a branch of veterinary medicine that focuses on the diagnosis, treatment, and prevention of diseases in horses. It involves the utilization of various products, such as vaccines, dewormers, topical treatments, joint supplements, prebiotics, fly sprays, hoof conditioners, antiseptics, and performance additives. Equine healthcare includes preventive care, illness management, lameness treatment, reproductive care, oral hygiene, rehabilitation, and addressing behavioral issues. It assists in improving overall health, preventing future complications, allowing early disease detection, facilitating successful breeding, promoting a longer lifespan, and reducing the risk of serious diseases, such as lameness, dental problems, infections, obesity, herpes, and rabies.
The rapid increase in the equine population due to the widespread utilization of horses in racing, farming, and as companions is one of the primary factors propelling the market growth. Equine healthcare services and products, such as preventive care, reproductive services, rehabilitation centers, vaccines, and health supplements, are widely used to ensure optimum performance, prevent complications, protect from injuries, and reduce the risk of illnesses. In addition to this, rising awareness among the owners regarding the importance of equine health and proper nutrition is acting as another growth-inducing factor. Furthermore, the implementation of various government initiatives to support animal welfare, promote responsible ownership, and provide access to high-quality healthcare facilities is positively influencing the market growth. Additionally, the utilization of advanced imaging techniques, such as digital radiography, ultrasound, and endoscopy, to provide detailed cross-sectional images of the horse's body, thus allowing the diagnosis of musculoskeletal injuries, lameness, and internal diseases, is contributing to the market growth. Besides this, the recent development of wearable health monitoring devices for horses, which allows continuous monitoring of vital signs, activity levels, and behavior to facilitate early detection of any health issues, is providing an impetus to the market growth. Moreover, the growing number of equine sports, such as racing, jumping, dressage, and endurance riding, is propelling the market growth. Other factors, including rising expenditure capacities of consumers, emerging trends of pet humanization, extensive research and development (R&D) activities, and rapid expansion of the e-commerce industry, are anticipated to drive the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global equine healthcare market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product, indication, and distribution channel.
Drugs
Anti-Inflammatory Drugs
Parasiticide Drugs
Others
Vaccines
Live Attenuated Vaccine
Recombinant Vaccine
Others
Medicated Feed Additives
Diagnostics
Others
The report has provided a detailed breakup and analysis of the equine healthcare market based on the product. This includes drugs (anti-inflammatory drugs, parasiticide drugs, and others), vaccines (live attenuated vaccine, recombinant vaccine, and others), medicated feed additives, diagnostics, and others. According to the report, drugs represented the largest segment.
Musculoskeletal Disorders
Parasite Control
Equine Herpes Virus
Equine Encephalomyelitis
Equine Influenza
West Nile Virus
Tetanus
Rabies
Others
A detailed breakup and analysis of the equine healthcare market based on the indication has also been provided in the report. This includes musculoskeletal disorders, parasite control, equine herpes virus, equine encephalomyelitis, equine influenza, West Nile virus, tetanus, rabies, and others. According to the report, parasite control accounted for the largest market share.
Veterinary Hospitals and Clinics
Retail Pharmacies and Drug Stores
A detailed breakup and analysis of the equine healthcare market based on the distribution channel has also been provided in the report. This includes veterinary hospitals and clinics and retail pharmacies and drug stores. According to the report, veterinary hospitals and clinics accounted for the largest market share.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for equine healthcare. Some of the factors driving the North America equine healthcare market included the rising equine population, supportive government policies, and significant technological advancements.
The report has also provided a comprehensive analysis of the competitive landscape in the global equine healthcare market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Boehringer Ingelheim International GmbH, Ceva, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Esaote SpA, Hallmarq Veterinary Imaging, IDEXX Laboratories Inc., Merck & Co. Inc., Vetoquinol S.A., Zoetis Inc, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.